Rational harm-benefit assessments by age group are required for continued COVID-19 vaccination

Scand J Immunol. 2023 Jul;98(1):e13242. doi: 10.1111/sji.13242. Epub 2022 Dec 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Humans

Substances

  • COVID-19 Vaccines